Cargando…

Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial

BACKGROUND: Benign prostatic hyperplasia (BPH) is a prevalent disease associated with lower urinary tract symptoms (LUTS). The standard of care for moderate-to-severe LUTS unresponsive to pharmacological treatment is the transurethral resection of the prostate (TURP). However, this intervention is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Napal Lecumberri, Saturnino, Insausti Gorbea, Iñigo, Sáez de Ocáriz García, Ana, Solchaga Álvarez, Saioa, Cebrián Lostal, José Luis, Monreal Beortegui, Raquel, Giral Villalta, Pedro José, Urtasun Grijalba, Fermín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815502/
https://www.ncbi.nlm.nih.gov/pubmed/29492398
http://dx.doi.org/10.2147/RRU.S139086
_version_ 1783300507673034752
author Napal Lecumberri, Saturnino
Insausti Gorbea, Iñigo
Sáez de Ocáriz García, Ana
Solchaga Álvarez, Saioa
Cebrián Lostal, José Luis
Monreal Beortegui, Raquel
Giral Villalta, Pedro José
Urtasun Grijalba, Fermín
author_facet Napal Lecumberri, Saturnino
Insausti Gorbea, Iñigo
Sáez de Ocáriz García, Ana
Solchaga Álvarez, Saioa
Cebrián Lostal, José Luis
Monreal Beortegui, Raquel
Giral Villalta, Pedro José
Urtasun Grijalba, Fermín
author_sort Napal Lecumberri, Saturnino
collection PubMed
description BACKGROUND: Benign prostatic hyperplasia (BPH) is a prevalent disease associated with lower urinary tract symptoms (LUTS). The standard of care for moderate-to-severe LUTS unresponsive to pharmacological treatment is the transurethral resection of the prostate (TURP). However, this intervention is not exempt from complications. Prostatic artery embolization (PAE) has been described as a new, effective and safe procedure for the treatment of LUTS secondary to BPH. To date, only one clinical trial has been published on the use of PAE for LUTS, but the study was methodologically flawed in terms of safety monitoring. Therefore, well-designed clinical studies are required to compare the efficacy and safety of both techniques in the treatment of LUTS secondary to BPH. METHODS AND DESIGN: This was a prospective, randomized, non-inferiority clinical trial comparing efficacy and safety of PAE and TURP in the treatment of BPH-related LUTS. A total of 60 patients diagnosed with BPH with obstructive moderate or severe LUTS refractory to medical therapy and candidates for TURP were randomized to either PAE or TURP. The presence and severity of LUTS were assessed using the validated Spanish version of the International Prostate Symptom Score (IPSS). Primary end points included improvement in maximum urinary flow rate (Q(max)) as measured at baseline and 1 year after the intervention. Improvement in IPSS as measured at baseline and after the intervention, reduction in prostate volume, no deterioration or improvement of sexual function (International Index of Erectile Function [IIEF]), reduction in PSA and PVR, satisfaction of the patient with the operation and adverse events occurring during the study were secondary outcome measures. DISCUSSION: The aim of this clinical study was to investigate whether PAE is a valid therapeutic option for LUTS that is not inferior to TURP in terms of efficacy and safety. This study also helped to define the profile of candidates for PAE and analyzed the benefits and complications associated with this new technique.
format Online
Article
Text
id pubmed-5815502
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58155022018-02-28 Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial Napal Lecumberri, Saturnino Insausti Gorbea, Iñigo Sáez de Ocáriz García, Ana Solchaga Álvarez, Saioa Cebrián Lostal, José Luis Monreal Beortegui, Raquel Giral Villalta, Pedro José Urtasun Grijalba, Fermín Res Rep Urol Original Research BACKGROUND: Benign prostatic hyperplasia (BPH) is a prevalent disease associated with lower urinary tract symptoms (LUTS). The standard of care for moderate-to-severe LUTS unresponsive to pharmacological treatment is the transurethral resection of the prostate (TURP). However, this intervention is not exempt from complications. Prostatic artery embolization (PAE) has been described as a new, effective and safe procedure for the treatment of LUTS secondary to BPH. To date, only one clinical trial has been published on the use of PAE for LUTS, but the study was methodologically flawed in terms of safety monitoring. Therefore, well-designed clinical studies are required to compare the efficacy and safety of both techniques in the treatment of LUTS secondary to BPH. METHODS AND DESIGN: This was a prospective, randomized, non-inferiority clinical trial comparing efficacy and safety of PAE and TURP in the treatment of BPH-related LUTS. A total of 60 patients diagnosed with BPH with obstructive moderate or severe LUTS refractory to medical therapy and candidates for TURP were randomized to either PAE or TURP. The presence and severity of LUTS were assessed using the validated Spanish version of the International Prostate Symptom Score (IPSS). Primary end points included improvement in maximum urinary flow rate (Q(max)) as measured at baseline and 1 year after the intervention. Improvement in IPSS as measured at baseline and after the intervention, reduction in prostate volume, no deterioration or improvement of sexual function (International Index of Erectile Function [IIEF]), reduction in PSA and PVR, satisfaction of the patient with the operation and adverse events occurring during the study were secondary outcome measures. DISCUSSION: The aim of this clinical study was to investigate whether PAE is a valid therapeutic option for LUTS that is not inferior to TURP in terms of efficacy and safety. This study also helped to define the profile of candidates for PAE and analyzed the benefits and complications associated with this new technique. Dove Medical Press 2018-02-13 /pmc/articles/PMC5815502/ /pubmed/29492398 http://dx.doi.org/10.2147/RRU.S139086 Text en © 2018 Napal Lecumberri et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Napal Lecumberri, Saturnino
Insausti Gorbea, Iñigo
Sáez de Ocáriz García, Ana
Solchaga Álvarez, Saioa
Cebrián Lostal, José Luis
Monreal Beortegui, Raquel
Giral Villalta, Pedro José
Urtasun Grijalba, Fermín
Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title_full Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title_fullStr Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title_full_unstemmed Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title_short Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
title_sort prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815502/
https://www.ncbi.nlm.nih.gov/pubmed/29492398
http://dx.doi.org/10.2147/RRU.S139086
work_keys_str_mv AT napallecumberrisaturnino prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT insaustigorbeainigo prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT saezdeocarizgarciaana prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT solchagaalvarezsaioa prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT cebrianlostaljoseluis prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT monrealbeorteguiraquel prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT giralvillaltapedrojose prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial
AT urtasungrijalbafermin prostaticarteryembolizationversustransurethralresectionoftheprostateinthetreatmentofbenignprostatichyperplasiaprotocolforanoninferiorityclinicaltrial